Stay updated with breaking news from Roberta Copeland. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Robert A. Copeland, Chief Scientific Officer, to provide major symposium presentation on inhibition of key RNA-modifying enzymes as precision cancer...
Ipsen adds another program into its pre-clinical R&D Oncology pipeline through an exclusive worldwide collaboration with Accent Therapeutics, targeting the RNA modifying protein, METTL3 ...
/PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company developing breakthrough, oncology-focused small molecule therapies that target RNA-modifying...
Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused
Press release content from Accesswire. The AP news staff was not involved in its creation.